State regulators eye direct caps on hospital prices

By Allison Bell – State insurance regulators could impose more limits on hospital prices and hospital price increases. Speakers talked about the idea Tuesday in San Diego, at a session at the National Association of Insurance Commissioners' spring national meeting. Adam Fox, the deputy director of the Colorado Consumer Health Initiative, and Lindsey Murtagh, a distinguished senior fellow at Brown University, briefed members of the NAIC's Health Care Affordability and Mitigation Workgroup on hospital services price controls while describing ways to make hospital care more affordable. Read Full Article... ^{_{(Subscription required)}}

HVBA Article Summary

1. Hospital Prices Driving Health Care Cost Growth: Hospitals accounted for 32% of U.S. health care cost growth between 2005 and 2024, with 61% of that increase linked to rising prices rather than greater use of services. Prices for inpatient care paid by private insurers have grown about twice as fast as those paid by Medicare and Medicaid. These trends have prompted policymakers to focus on hospital pricing as a major factor influencing overall health care spending.

2. States Considering Hospital Price Controls: Some states are exploring policies to regulate hospital prices, including flat price caps or limits on how quickly prices can increase. Policymakers must balance these limits carefully, as caps that are too high may allow prices to continue rising while caps that are too low could affect hospitals’ financial stability. Economists remain divided on the issue, with some supporting price controls due to hospitals’ strong bargaining position and others warning that strict limits could lead to provider exits or service shortages.

3. State Policies and Alternative Strategies Emerging: Several states have already implemented policies to manage hospital prices or related market dynamics. Rhode Island has limited hospital price increases to slightly above inflation, reducing insurance premiums but also lowering hospital revenue, while Oregon has capped prices for participants in the state employee health plan and reported savings without major hospital impacts. Policymakers are also considering additional strategies, including increased hospital financial transparency, stronger oversight of mergers and acquisitions, and limits on private equity ownership of hospitals.

CVS Caremark, FTC reach settlement in insulin pricing case

By Paige Minemyer – CVS Health's Caremark has become the second of the "Big Three" pharmacy benefit managers to reach a settlement with the Federal Trade Commission (FTC) in a lawsuit over insulin pricing. Per court documents (PDF) filed Monday, the parties have requested that the matter be withdrawn "for the purpose of considering a proposed consent agreement." Further details on the potential settlement have not yet been disclosed publicly, but a source familiar with the terms told Reuters the settlement is in line with the agreement the agency reached with Express Scripts last month. Read Full Article...

HVBA Article Summary

1. FTC Settlement Discussions with Major PBMs: The Federal Trade Commission filed a lawsuit in September 2024 against the three largest pharmacy benefit managers—CVS Caremark, Express Scripts, and Optum Rx—alleging that their business practices contributed to inflated insulin prices. The case followed a lengthy investigation into the role PBMs play in the prescription drug supply chain. The agency claimed certain contracting and pricing practices may have been anticompetitive and harmful to consumers.

2. Proposed Settlement with CVS Caremark: CVS has reached a proposed agreement with the FTC that would resolve the claims against Caremark in their entirety if the commission approves the settlement. A company spokesperson said CVS is pleased with the agreement and described it as consistent with initiatives the company has implemented in recent years. Final terms are still pending and will be confirmed after the agreement is reviewed by the FTC chairman.

3. Industry-Wide Progress Toward Resolution: Other PBMs involved in the case have also taken steps toward settlement. Express Scripts, a subsidiary of The Cigna Group, reached a settlement earlier in February that includes business changes intended to address insulin costs. The FTC has also indicated it is seeing progress in settlement discussions with Optum Rx, suggesting the broader dispute may move toward resolution.

Epic says AI charting for clinicians gets strong feedback

By Ron Southwick – Several weeks after launching a new AI-powered documentation tool, Epic says the company is seeing enthusiasm from clinicians. Garrett Adams, Epic’s vice president of research and development, says AI charting tools are getting good notices from clinicians. The electronic health records company just began offering the charting solution, which uses AI to record conversations with patients and offer summaries quickly, along with suggestions for orders. The technology is part of Art, Epic’s AI for clinicians. Epic launched the charting for doctors in February and just released charting for nurses in March. Read Full Article...

HVBA Article Summary

1. Epic Reports Positive Early Feedback on AI Charting Tool: Epic says early responses to its AI documentation system, “chart with Art,” have been largely positive among clinicians using the technology. The tool integrates with Epic’s electronic health record system and is designed to streamline documentation by automatically summarizing clinical conversations. Company leaders say the goal is to reduce time spent on charting, which is often cited as a contributor to clinician burnout.

2. AI Tools Aim to Improve Clinical Workflow and Patient Understanding: Epic’s AI charting can surface key information from previous visits and present it to clinicians in a condensed format before appointments. This feature is intended to help physicians prepare for patient encounters more efficiently and identify important details that may otherwise be overlooked. The technology also summarizes nurse–patient conversations, which may help patients better understand the care processes being discussed during visits.

3. Epic Pilots Conversational AI and Explores Predictive Medical Models: Epic is piloting a conversational feature that allows clinicians to ask questions about patient records aloud rather than typing into the system. The tool can answer simple questions, such as allergies, as well as more complex inquiries about treatment history. The company is also developing specialized “large medical models” designed to analyze clinical events and improve predictive analytics for disease risk, lab results, and potential procedures.

ICHRAs, local health networks empower employees to access better care

By Paola Peralta – Amid rising costs and confusion about access to care on employer-provided plans, the current healthcare model isn't working for employees, who are seeking better options from their organizational leaders. Forty-seven percent of employees cite high costs in their current plans, according to a recent survey from health-tech company Softheon. Another 34% report confusion about what their coverage includes, while 23% are concerned about poor communication between insurers and healthcare providers. Read Full Article... ^{_{(Subscription required)}}

HVBA Article Summary

1. Shift Toward Defined Contribution Models: Employers are increasingly moving away from traditional defined-benefit health plans and adopting Individual Coverage Health Reimbursement Arrangements (ICHRAs). This approach allows employers to offer a fixed monthly allowance for employees to purchase their own insurance, providing greater flexibility and control over healthcare choices. For employers, this model can help manage and predict healthcare spending more effectively.

2. Growing Interest in Local Provider-Sponsored Plans: Many employees express a preference for health plans offered by local hospitals or health systems, especially when costs are comparable to other options. These provider-sponsored plans can offer more integrated care, better communication between providers, and a more personalized experience for patients. The trend suggests that employees value healthcare options that are closely aligned with their local communities and existing provider relationships.

3. Importance of Tailored Benefits and Communication: Employers are encouraged to assess their workforce's unique needs and work with knowledgeable brokers or administrators to explore alternative healthcare solutions. Open communication and a clear understanding of employee demographics can help ensure that benefit offerings are both relevant and well-utilized. As employee expectations evolve, organizations must remain flexible and proactive in adapting their healthcare benefits to retain and support their workforce.

Women's health sector could grow to $600B industry by 2030: PwC report

By Cailey Gleeson – The global women’s health sector could reach $600 billion by 2030, but, when factoring in underdiagnosed conditions and new digital and consumer-directed models, the opportunity could be even larger, according to PwC. A new analysis (PDF) found the current global market for women’s health is estimated to be between $430 billion and $440 billion, representing a 6% to 8% annual growth rate by 2030. Moreover, the market for core women’s health—from gynecological conditions to oncology—is currently estimated at $195 billion to $205 billion and projected to reach $270 billion to $280 billion by 2030. Read Full Article...

HVBA Article Summary

1. Women’s Health Funding Gap: Women’s health receives approximately 5% of total healthcare research and development funding despite women making up about half of the global population. A January 2026 World Economic Forum report states that this disparity reflects not only equity concerns but also structural inefficiencies in how healthcare markets are defined and financed. Researchers suggest that current investment patterns may overlook significant healthcare needs and opportunities within the women’s health sector.

2. Expanding the Definition of Women’s Health: Researchers recommend applying a broader framework that includes conditions unique to women, conditions that affect women differently, and those that disproportionately affect women. This expanded definition highlights the need for continuous care across a woman’s lifetime rather than focusing primarily on reproductive health events. It also positions women’s health as a longitudinal healthcare market rather than a series of episodic treatments.

3. Investment Growth and Emerging Opportunities: Nearly $60 billion was invested in the women’s health sector between 2020 and 2025, with early funding largely focused on reproductive care. Areas such as women’s oncology and menopause are emerging as key growth segments as the sector expands. Researchers project continued growth through 2030 across multiple healthcare industries, supported by advances in digital health, artificial intelligence, improved diagnosis of underrecognized conditions, and expanded sex-specific research.

The Insurance Industry’s Old Trick: Flooding the Zone

By Wendell Potter – When the federal government opened a public comment period earlier this year on Medicare Advantage payment rates for 2027, which were far lower than what private health insurers had expected from the Trump administration, something remarkable happened. Comments poured in at a record-breaking pace — nearly 47,000 in all, an all-time high for a Medicare rate notice. Regulators took notice. A senior CMS official, perhaps trying to lighten the mood, joked that the flood of input might be “another innovation related to AI.” It was a good line. But the reality was less amusing. Read Full Article... ^{_{(Subscription required)}}

HVBA Article Summary

1. Comment Campaign Linked to Medicare Advantage Advocacy Group: An analysis of public comments submitted to federal regulators found that about 82% of more than 16,400 submissions were identical form letters connected to Medicare Advantage Majority, an advocacy group that does not disclose its funding sources. The letters warned that lower reimbursement rates could increase costs and reduce benefits for seniors. Some individuals whose names appeared on the comments said they were unaware their names had been used or did not knowingly submit a comment.

2. Industry-Funded Groups and Advertising Efforts Target Medicare Policy Debate: Insurance companies and affiliated organizations supported a broad campaign aimed at influencing discussions around Medicare Advantage payment rules. The effort included advertising campaigns, research sponsorships, lobbying activities, and messaging from groups that present themselves as grassroots organizations. Critics describe some of these tactics as “astroturfing,” a strategy that creates the appearance of widespread public support for industry positions.

3. Policy Dispute Centers on Proposed Limits to Medicare Advantage Payments: The policy debate is tied to a federal proposal to increase Medicare Advantage reimbursement rates by less than 0.1% in 2027 and tighten rules governing how insurers adjust for patient health risks. Independent analysts estimate that Medicare Advantage plans may receive about $76 billion in payments above what traditional Medicare would spend for comparable beneficiaries. Supporters of reform say the changes aim to reduce excess spending, while industry groups argue that payment reductions could negatively affect plan benefits and access for seniors.

What to know before asking an AI chatbot for health advice

By Matthew Perrone — With hundreds of millions of people turning to chatbots for advice, it was only a matter of time before tech companies began offering programs specifically designed to answer health questions. In January, OpenAI introduced ChatGPT Health, a new version of its chatbot that the company says can analyze users’ medical records, wellness apps and wearable device data to answer health and medical questions. Currently, there’s a waiting list for the program. Anthropic, a rival AI company, offers similar features for some users of its Claude chatbot. Read Full Article...

HVBA Article Summary

1. AI Chatbots Can Provide Personalized Health Information: Large language model chatbots can help summarize medical records, explain test results, and assist patients in preparing questions before doctor visits. Experts say these tools may provide more personalized and contextual information than general online searches when users include details such as age, prescriptions, and medical history. However, companies emphasize that chatbots are not a substitute for professional care and should not be used to diagnose medical conditions.

2. Limitations and Risks Require Careful Use: Medical experts advise that people experiencing serious symptoms, such as chest pain or shortness of breath, should seek immediate medical care instead of relying on AI chatbots. Research suggests that while chatbots can correctly identify conditions in structured written scenarios, real-world interactions with users may produce mixed or inaccurate guidance. Because responses may include both helpful and misleading information, experts recommend approaching chatbot advice with caution and not relying on it alone for medical decisions.

3. Privacy and Data Sharing Considerations: Many benefits of AI health tools depend on users sharing personal medical information, which helps chatbots generate more tailored responses. Unlike hospitals or doctors, AI companies are not covered by federal HIPAA privacy protections that govern the handling of medical records. Companies state that users must opt in to share health data and can disconnect at any time, and some experts suggest consulting multiple chatbots or sources to compare information and improve confidence in the results.